The Hair Loss Encyclopedia

Search

for
Search:

GlossaryTocilizumab

medication that inhibits IL-6 receptor to reduce inflammation

Tocilizumab, also known by the brand name Actemra, is a medication that targets the interleukin-6 (IL-6) receptor, which plays a role in the body's immune response. It is commonly used to treat autoimmune conditions such as rheumatoid arthritis and has also been explored for use in managing severe cases of COVID-19. By inhibiting IL-6, Tocilizumab helps reduce inflammation and modulate the immune system.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 80 results

Halo Nevi, Vitiligo, and Diffuse Alopecia Areata Associated with Tocilizumab Therapy

research Halo Nevi, Vitiligo, and Diffuse Alopecia Areata Associated with Tocilizumab Therapy

10 citations, August 2016 in “Oxford Medical Case Reports”

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Hair-Cycle Changes in Two Patients Taking Tocilizumab

research Hair-Cycle Changes in Two Patients Taking Tocilizumab

6 citations, August 2013 in “Joint Bone Spine”

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Hair Growth in a Patient with Alopecia Areata on Tocilizumab

research Hair Growth in a Patient with Alopecia Areata on Tocilizumab

1 citations, January 2021 in “Skin appendage disorders”

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Evidence Regarding the Use of the Monoclonal Antibody Tocilizumab as a Therapy for COVID-19

research Evidence Regarding the Use of the Monoclonal Antibody Tocilizumab as a Therapy for COVID-19

October 2022 in “Amplla Editora eBooks”

Tocilizumab might be an effective treatment for COVID-19.

Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations, November 2020 in “Dermatologic Therapy”

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

View more "tocilizumab" in research →

Community Join

0 / 0 results

— no results